Lineage Cell Therapeutics Inc
For the period ended Dec 31, 2024. Filed Mar 10, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 10, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| Date: March 10, 2025 | LINEAGE CELL THERAPEUTICS, INC. | |
|---|---|---|
| By: | /s/ Brian M. Culley | |
| Brian M. Culley | ||
| Chief Executive Officer | ||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Brian M. Culley | Chief Executive Officer and Director | March 10, 2025 |
| BRIAN M. CULLEY | (Principal Executive Officer) | |
| /s/ Jill Ann Howe | Chief Financial Officer | March 10, 2025 |
| JILL ANN HOWE | (Principal Financial and Accounting Officer) | |
| /s/ Deborah Andrews | Director | March 10, 2025 |
| DEBORAH ANDREWS | ||
| /s/ Dipti Amin | Director | March 10, 2025 |
| DIPTI AMIN | ||
| /s/ Don M. Bailey | Director | March 10, 2025 |
| DON M. BAILEY | ||
| /s/ Neal C. Bradsher | Director | March 10, 2025 |
| NEAL C. BRADSHER | ||
| /s/ Anula Jayasuriya | Director | March 10, 2025 |
| ANULA JAYASURIYA | ||
| /s/ Michael H. Mulroy | Director | March 10, 2025 |
| MICHAEL H. MULROY | ||
| /s/ Angus C. Russell | Director | March 10, 2025 |
| ANGUS C. RUSSELL | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.